Humasis Co. Ltd. (KOSDAQ: 205470)

Market Cap	200.40B
Revenue (ttm)	16.57B
Net Income (ttm)	-28.05B
Shares Out	113.15M
EPS (ttm)	-231.92
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,509,947
Average Volume	6,181,622
Open	1,776.00
Previous Close	1,771.00
Day's Range	1,775.00 - 1,823.00
52-Week Range	1,489.00 - 3,235.00
Beta	-1.04
RSI	46.34
Earnings Date	Mar 7, 2025

About Humasis

Humasis Co. Ltd. manufactures and sells pharmaceuticals and medical devices in South Korea and internationally. It offers immunodiagnostic kits, such as quantitative and qualitative tests, cardiac and cancer markers, infectious diseases, hormones, and women’s health. The company also provides bio-material products, such as COVID-19 nucleocapsid protein, human immunodeficiency virus surface proteins, COVID-19 RT-PCR kit, and COVID-19 Variant RT-qPCR kit, as well as MPXV real time PCR kit, a real-time polymerase chain reaction assay for the quali...

• Industry: In Vitro and In Vivo Diagnostic Substances
• Founded: 2000
• Employees: 71
• Stock Exchange: KOSDAQ
• Ticker Symbol: 205470